The Potential Impact of Probiotics on the Gut Microbiome of Athletes

Laura Wosinska, Paul D Cotter, Orla O'Sullivan, Caitriona Guinane, Laura Wosinska, Paul D Cotter, Orla O'Sullivan, Caitriona Guinane

Abstract

There is accumulating evidence that physical fitness influences the gut microbiome and as a result, promotes health. Indeed, exercise-induced alterations in the gut microbiome can influence health parameters crucial to athletic performance, specifically, immune function, lower susceptibility to infection, inflammatory response and tissue repair. Consequently, maintenance of a healthy gut microbiome is essential for an athlete's health, training and performance. This review explores the effect of exercise on the microbiome while also investigating the effect of probiotics on various potential consequences associated with over-training in athletes, as well as their associated health benefits.

Keywords: athletes; exercise; fitness; microbiome; overtraining; probiotic.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The effects of overtraining on the wellbeing of an athlete.
Figure 2
Figure 2
Decreased intestinal permeability.

References

    1. Janssens Y., Nielandt J., Bronselaer A., Debunne N., Verbeke F., Wynendaele E., Van Immerseel F., Vandewynckel Y.-P., De Tré G., De Spiegeleer B. Disbiome database: Linking the microbiome to disease. BMC Microbiol. 2018;18:50. doi: 10.1186/s12866-018-1197-5.
    1. Gill S.R., Pop M., DeBoy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355–1359. doi: 10.1126/science.1124234.
    1. Nash A.K., Auchtung T.A., Wong M.C., Smith D.P., Gesell J.R., Ross M.C., Stewart C.J., Metcalf G.A., Muzny D.M., Gibbs R.A., et al. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome. 2017;5:153. doi: 10.1186/s40168-017-0373-4.
    1. Lozupone C.A., Stombaugh J.I., Gordon J.I., Jansson J.K., Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220–230. doi: 10.1038/nature11550.
    1. O’Donovan C.M., O’Sullivan O., Cotter P.D. Gut Microbiol—A Relatively Unexplored Domain. Elsevier; Amsterdam, The Netherlands: 2018.
    1. Jandhyala S.M. Role of the normal gut microbiota. World J. Gastroenterol. 2015;21:8787. doi: 10.3748/wjg.v21.i29.8787.
    1. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., Nalin R., Jarrin C., Chardon P., Marteau P. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55:205–211. doi: 10.1136/gut.2005.073817.
    1. Arthur J.C., Perez-Chanona E., Mühlbauer M., Tomkovich S., Uronis J.M., Fan T.-J., Campbell B.J., Abujamel T., Dogan B., Rogers A.B. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338:120–123. doi: 10.1126/science.1224820.
    1. De Goffau M.C., Luopajarvi K., Knip M., Ilonen J., Ruohtula T., Harkonen T., Orivuori L., Hakala S., Welling G.W., Harmsen H.J., et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes. 2013;62:1238–1244. doi: 10.2337/db12-0526.
    1. Mach N., Fuster-Botella D. Endurance exercise and gut microbiota: A review. J. Sport Health Sci. 2017;6:179–197. doi: 10.1016/j.jshs.2016.05.001.
    1. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014;11:506–514. doi: 10.1038/nrgastro.2014.66.
    1. Shade A. Diversity is the question, not the answer. ISME J. 2017;11:1. doi: 10.1038/ismej.2016.118.
    1. Barton W., Penney N.C., Cronin O., Garcia-Perez I., Molloy M.G., Holmes E., Shanahan F., Cotter P.D., O’Sullivan O. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 2017;67:625–633. doi: 10.1136/gutjnl-2016-313627.
    1. Clarke S.F., Murphy E.F., O’Sullivan O., Lucey A.J., Humphreys M., Hogan A., Hayes P., O’Reilly M., Jeffery I.B., Wood-Martin R., et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63:1913–1920. doi: 10.1136/gutjnl-2013-306541.
    1. Petersen L.M., Bautista E.J., Nguyen H., Hanson B.M., Chen L., Lek S.H., Sodergren E., Weinstock G.M. Community characteristics of the gut microbiomes of competitive cyclists. Microbiome. 2017;5:98. doi: 10.1186/s40168-017-0320-4.
    1. Cronin O., Barton W., Skuse P., Penney N.C., Garcia-Perez I., Murphy E.F., Woods T., Nugent H., Fanning A., Melgar S., et al. A Prospective Metagenomic and Metabolomic Analysis of the Impact of Exercise and/or Whey Protein Supplementation on the Gut Microbiome of Sedentary Adults. MSystems. 2018;3:e00044. doi: 10.1128/mSystems.00044-18.
    1. Jang L.-G., Choi G., Kim S.-W., Kim B.-Y., Lee S., Park H. The combination of sport and sport-specific diet is associated with characteristics of gut microbiota: An observational study. J. Int. Soc. Sports Nutr. 2019;16:21. doi: 10.1186/s12970-019-0290-y.
    1. Scheiman J., Luber J.M., Chavkin T.A., MacDonald T., Tung A., Pham L.-D., Wibowo M.C., Wurth R.C., Punthambaker S., Tierney B.T. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat. Med. 2019;25:1104–1109. doi: 10.1038/s41591-019-0485-4.
    1. Meyer J.D., Koltyn K.F., Stegner A.J., Kim J.-S., Cook D.B. Influence of exercise intensity for improving depressed mood in depression: A dose-response study. Behav. Ther. 2016;47:527–537. doi: 10.1016/j.beth.2016.04.003.
    1. Duscha B.D., Slentz C.A., Johnson J.L., Houmard J.A., Bensimhon D.R., Knetzger K.J., Kraus W.E. Effects of exercise training amount and intensity on peak oxygen consumption in middle-age men and women at risk for cardiovascular disease. Chest. 2005;128:2788–2793. doi: 10.1378/chest.128.4.2788.
    1. Puetz T.W., Flowers S.S., O’Connor P.J. A randomized controlled trial of the effect of aerobic exercise training on feelings of energy and fatigue in sedentary young adults with persistent fatigue. Psychother. Psychosom. 2008;77:167–174. doi: 10.1159/000116610.
    1. Meeusen R., Duclos M., Foster C., Fry A., Gleeson M., Nieman D., Raglin J., Rietjens G., Steinacker J., Urhausen A. Prevention, diagnosis and treatment of the overtraining syndrome: Joint consensus statement of the European College of Sport Science (ECSS) and the American College of Sports Medicine (ACSM) Eur. J. Sport Sci. 2013;13:1–24. doi: 10.1080/17461391.2012.730061.
    1. Allen J.M., Berg Miller M.E., Pence B.D., Whitlock K., Nehra V., Gaskins H.R., White B.A., Fryer J.D., Woods J.A. Voluntary and forced exercise differentially alters the gut microbiome in C57BL/6J mice. J. Appl. Physiol. 2015;118:1059–1066. doi: 10.1152/japplphysiol.01077.2014.
    1. Karl J.P., Margolis L.M., Madslien E.H., Murphy N.E., Castellani J.W., Gundersen Y., Hoke A.V., Levangie M.W., Kumar R., Chakraborty N. Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress. Am. J. Physiol. Gastrointest. Liver Physiol. 2017;312:G559–G571. doi: 10.1152/ajpgi.00066.2017.
    1. Yuan X., Xu S., Huang H., Liang J., Wu Y., Li C., Yuan H., Zhao X., Lai X., Hou S. Influence of excessive exercise on immunity, metabolism, and gut microbial diversity in an overtraining mice model. Scand. J. Med. Sci. Sports. 2018;28:1541–1551. doi: 10.1111/sms.13060.
    1. Walsh N.P., Gleeson M., Shephard R.J., Gleeson M., Woods J.A., Bishop N., Fleshner M., Green C., Pedersen B.K., Hoffman-Goete L. Position Statement Part One: Immune Function and Exercise. Loughborough University; Loughborough, UK: 2011.
    1. Sina C., Gavrilova O., Förster M., Till A., Derer S., Hildebrand F., Raabe B., Chalaris A., Scheller J., Rehmann A.G. Protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J. Immunol. 2009;183:7514–7522. doi: 10.4049/jimmunol.0900063.
    1. Shouval D.S., Biswas A., Goettel J.A., McCann K., Conaway E., Redhu N.S., Mascanfroni I.D., Al Adham Z., Lavoie S., Ibourk M. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity. 2014;40:706–719. doi: 10.1016/j.immuni.2014.03.011.
    1. Sutterwala F.S., Noel G.J., Clynes R., Mosser D.M. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 1997;185:1977–1985. doi: 10.1084/jem.185.11.1977.
    1. Yano J.M., Yu K., Donaldson G.P., Shastri G.G., Ann P., Ma L., Nagler C.R., Ismagilov R.F., Mazmanian S.K., Hsiao E.Y. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264–276. doi: 10.1016/j.cell.2015.02.047.
    1. Valles-Colomer M., Falony G., Darzi Y., Tigchelaar E.F., Wang J., Tito R.Y., Schiweck C., Kurilshikov A., Joossens M., Wijmenga C. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 2019;4:623. doi: 10.1038/s41564-018-0337-x.
    1. Naseribafrouei A., Hestad K., Avershina E., Sekelja M., Linløkken A., Wilson R., Rudi K. Correlation between the human fecal microbiota and depression. Neurogastroenterol. Motil. 2014;26:1155–1162. doi: 10.1111/nmo.12378.
    1. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 1995;34:301–309. doi: 10.1016/0165-0327(95)00028-L.
    1. Margonis K., Fatouros I.G., Jamurtas A.Z., Nikolaidis M.G., Douroudos I., Chatzinikolaou A., Mitrakou A., Mastorakos G., Papassotiriou I., Taxildaris K. Oxidative stress biomarkers responses to physical overtraining: Implications for diagnosis. Free Radic. Biol. Med. 2007;43:901–910. doi: 10.1016/j.freeradbiomed.2007.05.022.
    1. Tanskanen M., Atalay M., Uusitalo A. Altered oxidative stress in overtrained athletes. J. Sports Sci. 2010;28:309–317. doi: 10.1080/02640410903473844.
    1. Hsu Y.J., Chiu C.C., Li Y.P., Huang W.C., Te Huang Y., Huang C.C., Chuang H.L. Effect of intestinal microbiota on exercise performance in mice. J. Strength Cond. Res. 2015;29:552–558. doi: 10.1519/JSC.0000000000000644.
    1. Xu J., Xu C., Chen X., Cai X., Yang S., Sheng Y., Wang T. Regulation of an antioxidant blend on intestinal redox status and major microbiota in early weaned piglets. Nutr. 2014;30:584–589. doi: 10.1016/j.nut.2013.10.018.
    1. Jeukendrup A., Vet-Joop K., Sturk A., Stegen J., Senden J., Saris W., Wagenmakers A. Relationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin. Sci. 2000;98:47–55. doi: 10.1042/cs0980047.
    1. Holland A.M., Hyatt H.W., Smuder A.J., Sollanek K.J., Morton A.B., Roberts M.D., Kavazis A.N. Influence of endurance exercise training on antioxidant enzymes, tight junction proteins, and inflammatory markers in the rat ileum. BMC Res. Notes. 2015;8:514. doi: 10.1186/s13104-015-1500-6.
    1. Schwellnus M.P., Derman W.E., Jordaan E., Page T., Lambert M.I., Readhead C., Roberts C., Kohler R., Collins R., Kara S. Elite athletes travelling to international destinations > 5 time zone differences from their home country have a 2–3-fold increased risk of illness. Br. J. Sports Med. 2012;46:816–821. doi: 10.1136/bjsports-2012-091395.
    1. Svendsen I.S., Taylor I.M., Tønnessen E., Bahr R., Gleeson M. Training-related and competition-related risk factors for respiratory tract and gastrointestinal infections in elite cross-country skiers. Br. J. Sports Med. 2016;50:809–815. doi: 10.1136/bjsports-2015-095398.
    1. Palleja A., Mikkelsen K.H., Forslund S.K., Kashani A., Allin K.H., Nielsen T., Hansen T.H., Liang S., Feng Q., Zhang C. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat. Microbiol. 2018;3:1255. doi: 10.1038/s41564-018-0257-9.
    1. Sode J., Obel N., Hallas J., Lassen A. Use of fluroquinolone and risk of Achilles tendon rupture: A population-based cohort study. Eur. J. Clin. Pharmacol. 2007;63:499–503. doi: 10.1007/s00228-007-0265-9.
    1. Wiström J., Norrby S.R., Myhre E.B., Eriksson S., Granström G., Lagergren L., Englund G., Nord C.E., Svenungsson B. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: A prospective study. J. Antimicrob. Chemother. 2001;47:43–50. doi: 10.1093/jac/47.1.43.
    1. Möller G.B., da Cunha Goulart M.J.V., Nicoletto B.B., Alves F.D., Schneider C.D. Supplementation of Probiotics and Its Effects on Physically Active Individuals and Athletes: Systematic Review. Int. J. Sport Nutr. Exerc. Metab. 2019;29:481–492. doi: 10.1123/ijsnem.2018-0227.
    1. Parvez S., Malik K.A., Ah Kang S., Kim H.Y. Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol. 2006;100:1171–1185. doi: 10.1111/j.1365-2672.2006.02963.x.
    1. PRNewswire Probiotics Market Will Register 7.5% CAGR to Exceed $67 Billion by 2024: Global Market Insights, Inc. [(accessed on 20 November 2018)]; Available online: .
    1. Santosa S., Farnworth E., Jones P.J. Probiotics and their potential health claims. Nutr. Rev. 2006;64:265–274. doi: 10.1111/j.1753-4887.2006.tb00209.x.
    1. Ramos C.L., Thorsen L., Schwan R.F., Jespersen L. Strain-specific probiotics properties of Lactobacillus fermentum, Lactobacillus plantarum and Lactobacillus brevis isolates from Brazilian food products. Food Microbiol. 2013;36:22–29. doi: 10.1016/j.fm.2013.03.010.
    1. Altenhoefer A., Oswald S., Sonnenborn U., Enders C., Schulze J., Hacker J., Oelschlaeger T.A. The probioticEscherichia colistrain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol. Med Microbiol. 2004;40:223–229. doi: 10.1016/S0928-8244(03)00368-7.
    1. Wehkamp J., Harder J., Wehkamp K., Wehkamp-von Meissner B., Schlee M., Enders C., Sonnenborn U., Nuding S., Bengmark S., Fellermann K. NF-κB-and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: A novel effect of a probiotic bacterium. Infect. Immun. 2004;72:5750–5758. doi: 10.1128/IAI.72.10.5750-5758.2004.
    1. Ukena S.N., Singh A., Dringenberg U., Engelhardt R., Seidler U., Hansen W., Bleich A., Bruder D., Franzke A., Rogler G., et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE. 2007;2:e1308. doi: 10.1371/journal.pone.0001308.
    1. Zyrek A.A., Cichon C., Helms S., Enders C., Sonnenborn U., Schmidt M.A. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell. Microbiol. 2007;9:804–816. doi: 10.1111/j.1462-5822.2006.00836.x.
    1. Chmielewska A., Szajewska H. Systematic review of randomised controlled trials: Probiotics for functional constipation. World J. Gastroenterol. 2010;16:69.
    1. Ukena S.N., Westendorf A.M., Hansen W., Rohde M., Geffers R., Coldewey S., Suerbaum S., Buer J., Gunzer F. The host response to the probiotic Escherichia coli strain Nissle 1917: Specific up-regulation of the proinflammatory chemokine MCP-1. BMC Med Genet. 2005;6:43. doi: 10.1186/1471-2350-6-43.
    1. Henker J., Laass M., Blokhin B.M., Bolbot Y.K., Maydannik V.G., Elze M., Wolff C., Schulze J. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur. J. Pediatr. 2007;166:311–318. doi: 10.1007/s00431-007-0419-x.
    1. De Smet I., Van Hoorde L., Vande Woestyne M., Christiaens H., Verstraete W. Significance of bile salt hydrolytic activities of lactobacilli. J. Appl. Bacteriol. 1995;79:292–301. doi: 10.1111/j.1365-2672.1995.tb03140.x.
    1. Pavlova S., Kilic A., Kilic S., So J.S., Nader-Macias M., Simoes J., Tao L. Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J. Appl. Microbiol. 2002;92:451–459. doi: 10.1046/j.1365-2672.2002.01547.x.
    1. Isolauri E., Kaila M., Mykkänen H., Ling W.H., Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig. Dis. Sci. 1994;39:2595–2600. doi: 10.1007/BF02087695.
    1. Vizoso Pinto M.G., Schuster T., Briviba K., Watzl B., Holzapfel W.H., Franz C.M.A.P. Adhesive and Chemokine Stimulatory Properties of Potentially Probiotic Lactobacillus Strains. J. Food Prot. 2007;70:125–134. doi: 10.4315/0362-028X-70.1.125.
    1. Oh N.S., Joung J.Y., Lee J.Y., Kim Y. Probiotic and anti-inflammatory potential of Lactobacillus rhamnosus 4B15 and Lactobacillus gasseri 4M13 isolated from infant feces. PLoS ONE. 2018;13:e0192021. doi: 10.1371/journal.pone.0192021.
    1. Reid G. The scientific basis for probiotic strains ofLactobacillus. Appl. Environ. Microbiol. 1999;65:3763–3766.
    1. Giwercman B., Jensen E., Høiby N., Kharazmi A., Costerton J. Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob. Agents Chemother. 1991;35:1008–1010. doi: 10.1128/AAC.35.5.1008.
    1. Cox A.J., Pyne D.B., Saunders P.U., Fricker P.A. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br. J. Sports Med. 2010;44:222–226. doi: 10.1136/bjsm.2007.044628.
    1. West N.P., Pyne D.B., Cripps A.W., Hopkins W.G., Eskesen D.C., Jairath A., Christophersen C.T., Conlon M.A., Fricker P.A. Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: A randomised control trial in athletes. Nutr. J. 2011;10:30. doi: 10.1186/1475-2891-10-30.
    1. Shing C.M., Peake J.M., Lim C.L., Briskey D., Walsh N.P., Fortes M.B., Ahuja K.D.K., Vitetta L. Effects of probiotics supplementation on gastrointestinal permeability, inflammation and exercise performance in the heat. Eur. J. Appl. Physiol. 2013;114:93–103. doi: 10.1007/s00421-013-2748-y.
    1. Hidalgo-Cantabrana C., Delgado S., Ruiz L., Ruas-Madiedo P., Sánchez B., Margolles A. Bifidobacteria and Their Health-Promoting Effects. Microbiol. Spectr. 2017;5
    1. Ruiz L., Margolles A., Sanchez B. Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Front. Microbiol. 2013;4:396. doi: 10.3389/fmicb.2013.00396.
    1. Junick J., Blaut M. Quantification of Human Fecal Bifidobacterium Species by Use of Quantitative Real-Time PCR Analysis Targeting thegroELGene. Appl. Environ. Microbiol. 2012;78:2613–2622. doi: 10.1128/AEM.07749-11.
    1. Selinger C.P., Bell A., Cairns A., Lockett M., Sebastian S., Haslam N. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. J. Hosp. Infect. 2013;84:159–165.
    1. Imaoka A., Shima T., Kato K., Mizuno S., Uehara T., Matsumoto S., Setoyama H., Hara T., Umesaki Y. Anti-inflammatory activity of probiotic Bifidobacterium: Enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J. Gastroenterol. 2008;14:2511–2516. doi: 10.3748/wjg.14.2511.
    1. West N.P., Horn P.L., Pyne D.B., Gebski V.J., Lahtinen S.J., Fricker P.A., Cripps A.W. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clin. Nutr. 2014;33:581–587. doi: 10.1016/j.clnu.2013.10.002.
    1. Haywood B.A., Black K.E., Baker D., McGarvey J., Healey P., Brown R.C. Probiotic supplementation reduces the duration and incidence of infections but not severity in elite rugby union players. J. Sci. Med. Sport. 2014;17:356–360. doi: 10.1016/j.jsams.2013.08.004.
    1. Jäger R., Purpura M., Stone J., Turner S., Anzalone A., Eimerbrink M., Pane M., Amoruso A., Rowlands D., Oliver J. Probiotic Streptococcus thermophilus FP4 and Bifidobacterium breve BR03 supplementation attenuates performance and range-of-motion decrements following muscle damaging exercise. Nutrients. 2016;8:642. doi: 10.3390/nu8100642.
    1. Pugh J.N., Sparks A.S., Doran D.A., Fleming S.C., Langan-Evans C., Kirk B., Fearn R., Morton J.P., Close G.L. Four weeks of probiotic supplementation reduces GI symptoms during a marathon race. Eur. J. Appl. Physiol. 2019;119:1491–1501. doi: 10.1007/s00421-019-04136-3.
    1. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Naturer. 2010;464:59–65. doi: 10.1038/nature08821.
    1. McFarland L.V. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med. Infect. Dis. 2007;5:97–105. doi: 10.1016/j.tmaid.2005.10.003.
    1. Thygesen J.B., Glerup H., Tarp B. Saccharomyces boulardii fungemia caused by treatment with a probioticum. BMJ Case Rep. 2012 doi: 10.1136/bcr.06.2011.4412.
    1. Choi C.H., Jo S.Y., Park H.J., Chang S.K., Byeon J.-S., Myung S.-J. A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: Effect on quality of life. J. Clin. Gastroenterol. 2011;45:679–683. doi: 10.1097/MCG.0b013e318204593e.
    1. Kurugöl Z., Koturoğlu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr. 2005;94:44–47. doi: 10.1080/08035250410022521.
    1. Billoo A., Memon M., Khaskheli S., Murtaza G., Iqbal K., Shekhani M.S., Siddiqi A.Q. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World J. Gastroenterol. 2006;12:4557. doi: 10.3748/wjg.v12.i28.4557.
    1. Walter J. Ecological Role of Lactobacilli in the Gastrointestinal Tract: Implications for Fundamental and Biomedical Research. Appl. Environ. Microbiol. 2008;74:4985–4996. doi: 10.1128/AEM.00753-08.
    1. Dugas B., Mercenier A., Lenoir-Wijnkoop I., Arnaud C., Dugas N., Postaire E. Immunity and probiotics. Immunol. Today. 1999;20:387–390. doi: 10.1016/S0167-5699(99)01448-6.
    1. Bezirtzoglou E., Stavropoulou E. Immunology and probiotic impact of the newborn and young children intestinal microflora. Anaerobe. 2011;17:369–374. doi: 10.1016/j.anaerobe.2011.03.010.
    1. Tulumoglu S., Yuksekdag Z.N., Beyatli Y., Simsek O., Cinar B., Yaşar E. Probiotic properties of lactobacilli species isolated from children’s feces. Anaerobe. 2013;24:36–42. doi: 10.1016/j.anaerobe.2013.09.006.
    1. Montes R., Bayless T.M., Saavedra J., Perman J. Effect of milks inoculated with Lactobacillus acidophilus or a yogurt starter culture in lactose-maldigesting children. J. Dairy Sci. 1995;78:1657–1664. doi: 10.3168/jds.S0022-0302(95)76790-X.
    1. Kim Y., Whang J.Y., Whang K.Y., Oh S., Kim S.H. Characterization of the Cholesterol-Reducing Activity in a Cell-Free Supernatant ofLactobacillus acidophilusATCC 43121. Biosci. Biotechnol. Biochem. 2014;72:1483–1490. doi: 10.1271/bbb.70802.
    1. Almeida C.C., Lorena S.L., Pavan C.R., Akasaka H.M., Mesquita M.A. Beneficial effects of long-term consumption of a probiotic combination of Lactobacillus casei Shirota and Bifidobacterium breve Yakult may persist after suspension of therapy in lactose-intolerant patients. Nutr. Clin. Pract. 2012;27:247–251. doi: 10.1177/0884533612440289.
    1. Kim J.Y., Kwon J.H., Ahn S.H., Lee S.I., Han Y.S., Choi Y.O., Lee S.Y., Ahn K.M., Ji G.E. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial. Pediatric Allergy Immunol. 2010;21:e386–e393. doi: 10.1111/j.1399-3038.2009.00958.x.
    1. Zanotti I., Turroni F., Piemontese A., Mancabelli L., Milani C., Viappiani A., Prevedini G., Sanchez B., Margolles A., Elviri L., et al. Evidence for cholesterol-lowering activity by Bifidobacterium bifidum PRL2010 through gut microbiota modulation. Appl. Microbiol. Biotechnol. 2015;99:6813–6829. doi: 10.1007/s00253-015-6564-7.
    1. Behnsen J., Deriu E., Sassone-Corsi M., Raffatellu M. Probiotics: Properties, examples, and specific applications. Cold Spring Harb. Perspect. Med. 2013;3:a010074. doi: 10.1101/cshperspect.a010074.
    1. Troy E.B., Kasper D.L. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front. Biosci. A J. Virtual Library. 2010;15:25. doi: 10.2741/3603.
    1. Curtis M.M., Hu Z., Klimko C., Narayanan S., Deberardinis R., Sperandio V. The Gut Commensal Bacteroides thetaiotaomicron Exacerbates Enteric Infection through Modification of the Metabolic Landscape. Cell Host Microbe. 2014;16:759–769. doi: 10.1016/j.chom.2014.11.005.
    1. Yanagibashi T., Hosono A., Oyama A., Tsuda M., Suzuki A., Hachimura S., Takahashi Y., Momose Y., Itoh K., Hirayama K., et al. IgA production in the large intestine is modulated by a different mechanism than in the small intestine: Bacteroides acidifaciens promotes IgA production in the large intestine by inducing germinal center formation and increasing the number of IgA + B cells. Immunobiology. 2013;218:645–651.
    1. Kirmiz N., Galindo K., Cross K.L., Luna E., Rhoades N., Podar M., Flores G.E. Comparative genomics guides elucidation of vitamin B12 biosynthesis in novel human associated Akkermansia. bioRxiv. 2019 doi: 10.1101/587527.
    1. Cani P.D., de Vos W.M. Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila. Front. Microbiol. 2017;8:1765. doi: 10.3389/fmicb.2017.01765.
    1. Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., Guiot Y., Derrien M., Muccioli G.G., Delzenne N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA. 2013;110:9066–9071. doi: 10.1073/pnas.1219451110.
    1. Shin N.-R., Lee J.-C., Lee H.-Y., Kim M.-S., Whon T.W., Lee M.-S., Bae J.-W. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014;63:727–735. doi: 10.1136/gutjnl-2012-303839.
    1. Plovier H., Everard A., Druart C., Depommier C., Van Hul M., Geurts L., Chilloux J., Ottman N., Duparc T., Lichtenstein L., et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 2016;23:107. doi: 10.1038/nm.4236.
    1. De Vos W.M., Müller M., Norin E., Hooiveld G., Van Baarlen P., Derrien M. Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Front. Microbiol. 2011;2:166.
    1. Sanz Y., Ottman N., Reunanen J., Meijerink M., Pietilä T.E., Kainulainen V., Klievink J., Huuskonen L., Aalvink S., Skurnik M., et al. Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS ONE. 2017;12:e0173004.
    1. Rossi O., van Berkel L.A., Chain F., Tanweer Khan M., Taverne N., Sokol H., Duncan S.H., Flint H.J., Harmsen H.J.M., Langella P., et al. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Sci. Rep. 2016;6:18507. doi: 10.1038/srep18507.
    1. Martín R., Miquel S., Chain F., Natividad J.M., Jury J., Lu J., Sokol H., Theodorou V., Bercik P., Verdu E.F., et al. Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol. 2015;15:67. doi: 10.1186/s12866-015-0400-1.
    1. Udayappan S., Manneras-Holm L., Chaplin-Scott A., Belzer C., Herrema H., Dallinga-Thie G.M., Duncan S.H., Stroes E.S., Groen A.K., Flint H.J. Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. NPJ Biofilms Microbiomes. 2016;2:16009. doi: 10.1038/npjbiofilms.2016.9.
    1. Engels C., Ruscheweyh H.-J., Beerenwinkel N., Lacroix C., Schwab C. The Common Gut Microbe Eubacterium hallii also Contributes to Intestinal Propionate Formation. Front. Microbiol. 2016;7:713. doi: 10.3389/fmicb.2016.00713.
    1. Fekry M.I., Engels C., Zhang J., Schwab C., Lacroix C., Sturla S.J., Chassard C. The strict anaerobic gut microbe Eubacterium hallii transforms the carcinogenic dietary heterocyclic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Environ. Microbiol. Rep. 2016;8:201–209. doi: 10.1111/1758-2229.12369.
    1. Kanauchi O., Fukuda M., Matsumoto Y., Ishii S., Ozawa T., Shimizu M., Mitsuyama K., Andoh A. Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity. World J. Gastroenterol. 2006;12:1071. doi: 10.3748/wjg.v12.i7.1071.
    1. Brubaker J.O., Li Q., Tzianabos A.O., Kasper D.L., Finberg R.W. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: Differential stimulatory effect on mouse and rat lymphocytes in vitro. J. Immunol. 1999;162:2235–2242.
    1. Hack V., Weiss C., Friedmann B., Suttner S., Schykowski M., Erbe N., Benner A., Bartsch P., Droge W. Decreased plasma glutamine level and CD4+ T cell number in response to 8 wk of anaerobic training. Am. J. Physiol. Endocrinol. Metab. 1997;272:E788–E795. doi: 10.1152/ajpendo.1997.272.5.E788.
    1. Laing S., Gwynne D., Blackwell J., Williams M., Walters R., Walsh N. Salivary IgA response to prolonged exercise in a hot environment in trained cyclists. Eur. J. Appl. Physiol. 2005;93:665–671. doi: 10.1007/s00421-004-1270-7.
    1. Mackinnon L.T., Ginn E., Seymour G.J. Decreased salivary immunoglobulin A secretion rate after intense interval exercise in elite kayakers. Eur. J. Appl. Physiol. Occup. Physiol. 1993;67:180–184. doi: 10.1007/BF00376664.
    1. Neville V., Gleeson M., Folland J.P. Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Med. Sci. Sports Exerc. 2008;40:1228–1236. doi: 10.1249/MSS.0b013e31816be9c3.
    1. Pals K.L., Chang R.-T., Ryan A.J., Gisolfi C.V. Effect of running intensity on intestinal permeability. J. Appl. Physiol. 1997;82:571–576. doi: 10.1152/jappl.1997.82.2.571.
    1. Øktedalen O., Lunde O., Opstad P., Aabakken L., Kvernebo K. Changes in the gastrointestinal mucosa after long-distance running. Scand. J. Gastroenterol. 1992;27:270–274. doi: 10.3109/00365529209000073.
    1. Soman V.R., Koivisto V.A., Deibert D., Felig P., DeFronzo R.A. Increased insulin sensitivity and insulin binding to monocytes after physical training. N. Engl. J. Med. 1979;301:1200–1204. doi: 10.1056/NEJM197911293012203.
    1. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L.G., Gratadoux J.-J., Blugeon S., Bridonneau C., Furet J.-P., Corthier G. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA. 2008;105:16731–16736. doi: 10.1073/pnas.0804812105.
    1. Chua K.J., Kwok W.C., Aggarwal N., Sun T., Chang M.W. Designer probiotics for the prevention and treatment of human diseases. Curr. Opin. Chem. Biol. 2017;40:8–16. doi: 10.1016/j.cbpa.2017.04.011.
    1. Amalaradjou M.A., Bhunia A.K. Bioengineered probiotics, a strategic approach to control enteric infections. Bioengineered. 2013;4:379–387. doi: 10.4161/bioe.23574.
    1. Doron S., Snydman D.R. Risk and safety of probiotics. Clin. Infect. Dis. 2015;60(suppl. 2):S129–S134. doi: 10.1093/cid/civ085.
    1. Panel E.F. Guidance on the Characterisation Microorganisms 1 Used as Feed Additives or as Production Organisms. EFSA; Parma, Italy: 2017.
    1. Organisation W.G. Probiotics and Prebiotic. WGO; Forest City, IA, USA: 2017.
    1. Health N.I.O. Probiotics. [(accessed on 25 June 2019)]; Available online:
    1. Timmerman H., Koning C., Mulder L., Rombouts F., Beynen A. Monostrain, multistrain and multispecies probiotics—A comparison of functionality and efficacy. Int. J. Food Microbiol. 2004;96:219–233. doi: 10.1016/j.ijfoodmicro.2004.05.012.
    1. Anadón A., Martínez-Larrañaga M.R., Arés I., Martínez M.A. Nutraceuticals in Veterinary Medicine. Springer; Berlin/Heidelberg, Germany: 2016. Prebiotics and Probiotics in Feed and Animal Health; pp. 3–23.
    1. Helenius I.J., Tikkanen H.O., Sarna S., Haahtela T. Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors. J. Allergy Clin. Immunol. 1998;101:646–652. doi: 10.1016/S0091-6749(98)70173-3.
    1. Nieman D.C., Johanssen L.M., Lee J.W., Arabatzis K. Infectious episodes in runners before and after the Los Angeles Marathon. J Sports Med. Phys. Fit. 1990;30:316–328.
    1. Spence L., Brown W.J., Pyne D.B., Nissen M.D., Sloots T.P., McCormack J.G., Locke A.S., Fricker P.A. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Med. Sci. Sports Exerc. 2007;39:577–586. doi: 10.1249/mss.0b013e31802e851a.
    1. Ter Steege R.W., Van Der Palen J., Kolkman J.J. Prevalence of gastrointestinal complaints in runners competing in a long-distance run: An internet-based observational study in 1281 subjects. Scand. J. Gastroenterol. 2008;43:1477–1482. doi: 10.1080/00365520802321170.
    1. Gouttebarge V., Frings-Dresen M., Sluiter J. Mental and psychosocial health among current and former professional footballers. Occup. Med. 2015;65:190–196. doi: 10.1093/occmed/kqu202.
    1. Martarelli D., Verdenelli M.C., Scuri S., Cocchioni M., Silvi S., Cecchini C., Pompei P. Effect of a Probiotic Intake on Oxidant and Antioxidant Parameters in Plasma of Athletes During Intense Exercise Training. Curr. Microbiol. 2011;62:1689–1696. doi: 10.1007/s00284-011-9915-3.
    1. Lamprecht M., Frauwallner A. Exercise, intestinal barrier dysfunction and probiotic supplementation. Med. Sport Sci. 2012;59:47–56.
    1. Clancy R., Gleeson M., Cox A., Callister R., Dorrington M., D’este C., Pang G., Pyne D., Fricker P., Henriksson A. Reversal in fatigued athletes of a defect in interferon γ secretion after administration of Lactobacillus acidophilus. Br. J. Sports Med. 2006;40:351–354. doi: 10.1136/bjsm.2005.024364.
    1. Sashihara T., Nagata M., Mori T., Ikegami S., Gotoh M., Okubo K., Uchida M., Itoh H. Effects of Lactobacillus gasseri OLL2809 and α-lactalbumin on university-student athletes: A randomized, double-blind, placebo-controlled clinical trial. Appl. Physiol. Nutr. Metab. 2013;38:1228–1235. doi: 10.1139/apnm-2012-0490.
    1. Strasser B., Geiger D., Schauer M., Gostner J.M., Gatterer H., Burtscher M., Fuchs D. Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial. Nutrients. 2016;8:752. doi: 10.3390/nu8110752.
    1. Wang Y., Wu Y., Wang Y., Xu H., Mei X., Yu D., Wang Y., Li W. Antioxidant Properties of Probiotic Bacteria. Nutrients. 2017;9:521. doi: 10.3390/nu9050521.
    1. Saide J., Gilliland S. Antioxidative activity of lactobacilli measured by oxygen radical absorbance capacity. J. Dairy Sci. 2005;88:1352–1357. doi: 10.3168/jds.S0022-0302(05)72801-0.
    1. Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., Muir A.I., Wigglesworth M.J., Kinghorn I., Fraser N.J. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003;278:11312–11319. doi: 10.1074/jbc.M211609200.
    1. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., Deroos P., Liu H., Cross J.R., Pfeffer K., Coffer P.J. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451. doi: 10.1038/nature12726.
    1. Gao Z., Yin J., Zhang J., Ward R.E., Martin R.J., Lefevre M., Cefalu W.T., Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58:1509–1517. doi: 10.2337/db08-1637.
    1. Zuhl M., Schneider S., Lanphere K., Conn C., Dokladny K., Moseley P. Exercise regulation of intestinal tight junction proteins. Br. J. Sports Med. 2014;48:980–986. doi: 10.1136/bjsports-2012-091585.
    1. Wells J.M., Konstaninov S., Konings I., Karczewski J. Effects of probiotic and commensals on epithelial barrier function. Int. J. Probiotics Prebiotics. 2008;3:127–132.
    1. Lamprecht M., Bogner S., Schippinger G., Steinbauer K., Fankhauser F., Hallstroem S., Schuetz B., Greilberger J.F. Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J. Int. Soc. Sports Nutr. 2012;9:45. doi: 10.1186/1550-2783-9-45.
    1. Hackney A.C., Koltun K.J. The immune system and overtraining in athletes: Clinical implications. Acta Clin. Croat. 2012;51:633–641.
    1. West N., Pyne D., Peake J., Cripps A. Probiotics, immunity and exercise: A review. Exerc. Immunol. Rev. 2009;15:e26.
    1. Mack D.R., Michail S., Wei S., McDougall L., Hollingsworth M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 1999;276:G941–G950. doi: 10.1152/ajpgi.1999.276.4.G941.
    1. Snyder J.D., Walker A. Structure and Function of Intestinal Mucin: Developmental Aspects. Int. Arch. Allergy Immunol. 1987;82:351–356. doi: 10.1159/000234225.
    1. Möndel M., Schroeder B., Zimmermann K., Huber H., Nuding S., Beisner J., Fellermann K., Stange E., Wehkamp J. Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans. Mucosal Immunol. 2009;2:166. doi: 10.1038/mi.2008.77.
    1. Kekkonen R.A., Vasankari T.J., Vuorimaa T., Haahtela T., Julkunen I., Korpela R. The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners. Int. J. Sport Nutr. Exerc. Metab. 2007;17:352–363. doi: 10.1123/ijsnem.17.4.352.
    1. Peters E.M., Bateman E. Ultramarathon running and upper respiratory tract infections. An epidemiological survey. S. Afr. Med J. 1983;64:582–584.
    1. Romano R., Lu D., Holtom P. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among a collegiate football team. J. Athl. Train. 2006;41:141.
    1. Suskovic J. Antimicrobial Activity—The Most Important Property of probiotic and starter lactic acid bacteria. Food Technol. Biotechnol. 2010;48:296–307.
    1. Shokryazdan P., Sieo C.C., Kalavathy R., Liang J.B., Alitheen N.B., Faseleh Jahromi M., Ho Y.W. Probiotic potential of Lactobacillus strains with antimicrobial activity against some human pathogenic strains. BioMed Res. Int. 2014;2014:927268. doi: 10.1155/2014/927268.
    1. Cotter P.D., Hill C., Ross R.P. Food microbiology: Bacteriocins: Developing innate immunity for food. Nature Rev. Microbiol. 2005;3:777. doi: 10.1038/nrmicro1273.
    1. Hegarty J.W., Guinane C.M., Ross R.P., Hill C., Cotter P.D. Bacteriocin production: A relatively unharnessed probiotic trait? F1000Research. 2016;5:2587. doi: 10.12688/f1000research.9615.1.
    1. Dobson A., Cotter P.D., Ross R.P., Hill C. Bacteriocin Production: A Probiotic Trait? Appl. Environ. Microbiol. 2012;78:1–6. doi: 10.1128/AEM.05576-11.
    1. Hegarty J.W., Guinane C.M., Ross R.P., Hill C., Cotter P.D. Lack of Heterogeneity in Bacteriocin Production Across a Selection of Commercial Probiotic Products. Probiotics Antimicrob. Proteins. 2017;9:459–465. doi: 10.1007/s12602-017-9326-2.
    1. Reardon C.L., Hainline B., Aron C.M., Baron D., Baum A.L., Bindra A., Budgett R., Campriani N., Castaldelli-Maia J.M., Currie A. Mental health in elite athletes: International Olympic Committee consensus statement. Br. J. Sports Med. 2019;53:667–699. doi: 10.1136/bjsports-2019-100715.
    1. Dougherty D.M., Marsh-Richard D.M., Mathias C.W., Hood A.J., Addicott M.A., Moeller F.G., Morgan C.J., Badawy A.A.-B. Comparison of 50-and 100-g L-tryptophan depletion and loading formulations for altering 5-HT synthesis: Pharmacokinetics, side effects, and mood states. Psychopharmacology. 2008;198:431. doi: 10.1007/s00213-008-1163-2.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj